Nasdaq GlobeNewswire

Akiem and Bombardier sign contracts to supply a total of 33 TRAXX locomotives

Del
  • Orders include TRAXX AC3, DC3 and MS2 locomotives
  • Designed for operation under Europe’s main voltages, the locomotives offer Akiem and its customers flexibility and efficiency

BERLIN, Nov. 09, 2018 (GLOBE NEWSWIRE) --

Note to editors: To view the photos associated with this press release, please visit the following links:

http://www.globenewswire.com/NewsRoom/AttachmentNg/00415160-ab8e-45ba-8d33-d1be57d86596

http://www.globenewswire.com/NewsRoom/AttachmentNg/28dfb159-ba35-4510-90c9-c608c4c7aa2f

http://www.globenewswire.com/NewsRoom/AttachmentNg/bb26f09a-3989-4590-b839-4759503c055a

Rolling stock leasing company Akiem and mobility technology leader Bombardier Transportation have signed two contracts under frame contracts to deliver a total of 33 BOMBARDIER TRAXX locomotives. Based on their list price, the two firm orders are valued at a combined total of €112 million ($128 million US). Scheduled for delivery between 2019 and 2021 at the latest, the 33 TRAXX locomotives will consist of a mix of TRAXX MS 2 (multi-system), TRAXX AC 3 (alternating current) and TRAXX DC3 (direct current) locomotives.

Fabien Rochefort, CEO of Akiem Group, said, “This additional batch of 33 TRAXX locomotives meets our customers’ demand across Europe. With a fleet of 180 TRAXX by 2020, we are strengthening our ability to deliver reliable, efficient, safe and cost-effective traction services expected by both passenger and freight operators. This fruitful partnership with Bombardier Transportation enables Akiem Group industrial teams to design and deliver tailor-made services and maintenance solutions across Europe. We are making our Group a major long-term, reliable partner and added value provider for the railway transport industry in Europe.”

Peter Ammann, Head of Ecosystem Freight Corridors, Bombardier Transportation, added, “We are very pleased to have received these additional locomotive orders from Akiem, further strengthening our partnership with this important customer. We introduced our versatile TRAXX locomotives platform 18 years ago and since then have continuously innovated and improved its features. With over 2,200 units sold, the platform has demonstrated its success. With these recent orders, Akiem will own a fleet of 180 TRAXX locomotives; the customer continues to benefit from this mixture of performance, experience and permanent evolution.”

The BOMBARDIER TRAXX 3 platform is the most modern four-axle locomotive platform in Europe. Its three models, T RAXX AC3, TRAXX MS3 and TRAXX DC3, all offer optional Last Mile function, a support diesel engine which bridges non-electrified sections.

The TRAXX MS locomotive plays a crucial role in the development of economies in Europe. Designed to operate on Europe’s four main rail supply voltages – 15 kV and 25 kV AC as well as 1.5 and 3 kV DC – it offers the necessary flexibility and interoperability to manage international rail transport across the continent.

About Akiem Group
Akiem Group is a major player in locomotive leasing and related services in Europe. It has the benefit of the maintenance network of its subsidiary, mgw Service, which specialises in rail equipment maintenance. As the owner of a 440-strong locomotive fleet, Akiem Group generates revenue of €140 million with some 50 customers, who operate in freight or passenger transport in most European countries. Almost 150 employees based in France, Germany, Sweden, Italy and Poland work for the leasing and maintenance business units of Akiem Group, which is held by Transport et Logistique Partenaires and DWS.

About Bombardier Transportation
Bombardier Transportation is a global mobility solution provider leading the way with the rail industry’s broadest portfolio. It covers the full spectrum of solutions, ranging from trains to sub-systems and signalling to complete turnkey transport systems, e-mobility technology and data-driven maintenance services. Combining technology and performance with empathy, Bombardier Transportation continuously breaks new ground in sustainable mobility by providing integrated solutions that create substantial benefits for operators, passengers and the environment. Headquartered in Berlin, Germany, Bombardier Transportation employs around 39,850 people and its products and services operate in over 60 countries.

About Bombardier
With over 69,500 employees across four business segments, Bombardier is a global leader in the transportation industry, creating innovative and game-changing planes and trains. Our products and services provide world-class transportation experiences that set new standards in passenger comfort, energy efficiency, reliability and safety.

Headquartered in Montreal, Canada, Bombardier has production and engineering sites in 28 countries across the segments of Transportation, Business Aircraft, Commercial Aircraft, and Aerostructures and Engineering Services. Bombardier shares are traded on the Toronto Stock Exchange (BBD). In the fiscal year ended December 31, 2017, Bombardier posted revenues of $16.2 billion US. News and information are available at bombardier.com or follow us on Twitter @Bombardier.

Notes to editors
For news, related material and photos, visit our newsroom at www.rail.bombardier.com/en/newsroom.html. Please subscribe to our RSS Feed to receive press releases or follow Bombardier Transportation on Twitter @BombardierRail.

Bombardier and TRAXX are trademarks of Bombardier Inc. or its subsidiaries.

For information

Akiem Bombardier
Group communications coordinator
Valérie Barral
+33 1 80 43 01 74
valerie.barral@akiem.com
Global media relations
+49 30 98607 1687
press@rail.bombardier.com

You can also contact one of our worldwide contacts for specific press enquiries.

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Bombardier Will Fully Cooperate with the AMF Review16.11.2018 00:06Pressemelding

MONTRÉAL, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Bombardier acknowledges the announcement by the Autorité des marchés financiers (AMF) that it is reviewing the operations surrounding the establishment by Bombardier of an Automatic Securities Disposition Plan (ASDP) in August 2018 and various subsequent announcements. The ASDP had been reviewed by the AMF prior to its establishment on August 15, 2018. Bombardier intends to fully cooperate with the AMF in its review. The Company has taken the necessary measures to suspend all sales of securities pursuant to the ASDP until further notice. About Bombardier With over 69,500 employees across four business segments, Bombardier is a global leader in the transportation industry, creating innovative and game-changing planes and trains. Our products and services provide world-class transportation experiences that set new standards in passenger comfort, energy efficiency, reliability and safety. Headquartered in Montreal, Canada, Bombardier has product

ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research15.11.2018 22:05Pressemelding

LYON, France and CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced a strategic partnership with New York Blood Center (NYBC) for red blood cell supply and research. The partnership encompasses NYBC becoming a long-term supplier of donor red blood cells (RBC) to ERYTECH, enabling ERYTECH to diversify and broaden its supply of RBC source materials for the production of eryaspase and future product candidates derived from its proprietary ERYCAPS® platform as the company ramps up clinical development. Specifically for the Phase 3 trial in second-line metastatic pancreatic cancer that recently started enrolling patients in Europe, and the Phase 2 trial in first-line triple negative breast cancer (TNBC), which are both expected to begin enrollment in the United States early in 2019. The partnershi

Zageno Deepens Engagement with Scientists and Vendors through Its Meaningful and Unbiased Rating System for Scientific Products — Scientific Score gets Algorithm Update15.11.2018 15:37Pressemelding

Call for Contributions: Zageno’s rating system for scientific products — the Scientific Score — adds a crucial dimension to help research scientists purchase the right material for their experiment. Scientists: share your experimental data and professional experience about products; Life Science Vendors: provide additional product-specific resources and data points to make your products reach the right scientist CAMBRIDGE, Mass. USA and BERLIN, Germany, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Zageno Inc., the largest and fastest-growing online marketplace for research materials, today issues an open call for scientists and vendors alike to contribute to the continuous improvement of the Scientific Score. Designed as an unbiased indicator to help purchasing scientists navigate the enormous amount of product information, the Scientific Score is the result of proprietary algorithms calculating and weighing different data points across multiple information formats. Among others, factors like rec

Motiv Ring Expands International Footprint and Delivers Industry-First Sizing Process15.11.2018 15:00Pressemelding

The wearable ring lands in 20 new countries and eight new stores, and introduces frictionless sizing method SAN FRANCISCO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Motiv Inc., creators of breakthrough wearable technology, today announced an increase of its product availability through new international availability and a new digital sizing set alternative. Motiv Ring’s international expansion will be through its website MyMotiv.com. Featured countries include: North America (Canada), Europe (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Lithuania, Latvia, Netherlands, Poland, Portugal, Spain, Sweden, United Kingdom, Norway and Switzerland), as well as Japan, Taiwan, Turkey, Australia and New Zealand. Good fit is imperative to great functionality. To date, Motiv Ring users select their sizes after receiving a physical sizing kit in the mail. Releasing in Open Beta , Motiv Ring users will now have the additional option of determining their Motiv size via a

SignalFx Delivers Next Generation of Application Performance Monitoring15.11.2018 15:00Pressemelding

The first to enable directed troubleshooting for applications and microservices SAN MATEO, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- SignalFx, the leader in real-time cloud monitoring for infrastructure, microservices, and applications, today unveiled SignalFx Microservices APM™, the industry’s first real-time application performance monitoring solution designed to accelerate troubleshooting for DevOps teams through advanced real-time analytics. Powered by NoSample™ distributed tracing architecture, SignalFx Microservices APM observes every single transaction – not just a small random sample – and reports on every anomaly. With the new Outlier Analyzer™, the most challenging issues can now be pinpointed and resolved with a single click. SignalFx Microservices APM is built on top of SignalFx’s advanced streaming analytics platform for metrics which applies unsurpassed data science in real-time to identify the root cause of critical application problems. Integration with advanced automat

Minerva Neurosciences to Host Roluperidone Update and Key Opinion Leader Discussion of Negative Symptoms in CNS/Psychiatric Diseases on November 20, 201815.11.2018 14:30Pressemelding

Minerva management to provide update on Phase 3 clinical trial with roluperidone and single-dose escalation study findings Additional topics to include review of recent BDNF data with roluperidone and KOL discussion of trans-diagnostic approach to treating negative symptoms in CNS/psychiatry diseases WALTHAM, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will host a roluperidone update and key opinion leader event on Tuesday, November 20, 2018 beginning at 8:00 a.m. Eastern Time in New York. Members of Minerva’s senior management will be joined by an expert key opinion leader. Discussions will feature the following speakers and topics: Gregory P. Strauss, Ph.D., Assistant Professor; Director: Clinical Affective Neuroscience Laboratory; Director: Georgia Psychiatric Risk Evaluation Program; Depa

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom